Abstract
The crystallo-co-agglomeration technique was used to design directly compressible and deformable agglomerates of talc containing the low-dose drug bromhexine hydrochloride (BXH). The process of agglomeration involved the use of dichloromethane as a good solvent and bridging liquid for BXH, water as a poor solvent, talc as diluent, and Tween 80 to aid dispersion of BXH and diluent into the poor solvent. Hydroxypropyl methylcellulose (50 cps) 4% wt/wt was used to impart the desired mechanical strength and polyethylene glycol 6000 5% wt/wt was used to impart the desired sphericity to the agglomerates. Clarity of the supernatant was considered an endpoint for completion of the agglomeration process. The drug-to-talc ratio in optimized batch 1 (BT1) and batch 2 (BT2) was kept at 1:15.66 and 1:24, respectively. The spherical agglomerates obtained were evaluated for topographic, micromeritic, mechanical, deformation, compressional, and drug release properties. The agglomeration yield and drug entrapment for both batches were above 94% wt/wt. Crushing strength and friability studies showed good handling qualities of agglomerates. Heckel plot studies showed low mean yield pressure and high tensile strength, indicating excellent compressibility and compactibility of agglomerates. Diametral and axial fracture of compacts showed deformation of agglomerates revealing formation of a heterogeneous compact. Drug release was sustained for 9 hours and 5 hours from BT1 and BT2, respectively, in 0.1N HCl. Hence, the crystallo-co-agglomeration technique can be successfully used for obtaining spherical, deformable, and directly compressible agglomerates, generating a heterogeneous matrix system and providing sustained drug release.
Keywords: Crystallo-co-agglomeration, deformable agglomerates, heterogeneous compact, sustained release
Full Text
The Full Text of this article is available as a PDF (233.0 KB).
References
- 1.Kadam SS, Mahadik KR, Paradkar AR, inventors. Vidyapeeth B, assignee. A process for making agglomerates for use as or in a drug delivery system. Indian patent 183 036. February 14, 1997.
- 2.Kadam SS, Mahadik KR, Paradkar AR, inventors. Vidyapeeth B, assignee. A process for making agglomerates for use as or in a drug delivery system. Indian patent 183 481. February 14, 1997.
- 3.Pawar AP, Paradkar AR, Kadam SS, Mahadik KR. Agglomeration of ibuprofen with talc by novel crystallo-co-agglomeration technique [serial online] AAPS Pharm Sci Tech. 2004;5:E55–E55. doi: 10.1208/pt050455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pawar AP, Paradkar AR, Kadam SS, Mahadik KR. Crystallo-co-agglomeration: a novel process to obtain ibuprofen-paracetamol agglomerates [serial online] AAPS Pharm Sci Tech. 2004;5:E44–E44. doi: 10.1208/pt050344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jarosz PJ, Parrot EJ. Comparison of granule strength and tablet strength. J Pharm Sci. 1983;72:530–535. doi: 10.1002/jps.2600720513. [DOI] [PubMed] [Google Scholar]
- 6.Makio N, Kenji N, Tadashi H, Akinobu I, Toyokazu Y, Hidehiro K. Microscopic analysis on the consolidation process of granule beds. Powder Technol. 1998;95:214–219. doi: 10.1016/S0032-5910(97)03340-8. [DOI] [Google Scholar]
- 7.Cheonga YS, Adamsb MJ, Routha AF, Hounslowa MJ, Salmana AD. The production of binderless granules, and their mechanical characteristics. Chem Eng, Sci. 2005;60:4045–4053. doi: 10.1016/j.ces.2005.02.033. [DOI] [Google Scholar]
- 8.Salako M, Podczek F, Newton JM. Investigations into the deformability and tensile strength of pellets. Int J Pharm. 1998;168:49–57. doi: 10.1016/S0378-5173(98)00077-5. [DOI] [Google Scholar]
- 9.Lundqvist AEK, Podczeck F, Newton JM. Influence of disintegrant type and proportion on the properties of tablets produced from mixtures of pellets. Int J Pharm. 1997;147:95–107. doi: 10.1016/S0378-5173(96)04800-4. [DOI] [Google Scholar]
- 10.Pinto JF, Podczeck F, Newton JM. Investigations of tablets prepared from pellets produced by extrusion and spheronisation. Part I: the application of canonical analysis to correlate the properties of the tablets to the factors studied in combination with principal component analysis to select the most relevant factors. Int J Pharm. 1997;147:79–93. doi: 10.1016/S0378-5173(96)04792-8. [DOI] [Google Scholar]
- 11.Vergote GJ, Kiekens F, Vervaet C, Remon JP. Wax beads as cushioning agents during the compression of coated diltiazem pellets. Eur J Pharm Sci. 2002;17:145–151. doi: 10.1016/S0928-0987(02)00164-1. [DOI] [PubMed] [Google Scholar]
- 12.Beckert TE, Lehmann K, Schmidt PC. Compression of enteric-coated pellets to disintegrating tablets. Int J Pharm. 2007;143:13–23. doi: 10.1016/S0378-5173(96)04631-5. [DOI] [Google Scholar]
- 13.Dashevsky A, Kolter K, Bodmeier R. Compression of pellets coated with various aqueous polymer dispersions. Int J Pharm. 2004;279:19–26. doi: 10.1016/j.ijpharm.2004.03.019. [DOI] [PubMed] [Google Scholar]
- 14.Morishima K, Kawashima Y, Takeuchi H, Niwa T, Hino T. Micromeritic characteristics and agglomeration mechanisms in the spherical crystallization of bucillamine by the spherical agglomeration and the emulsion, solvent diffusion methods. Powder Technol. 1993;76:57–64. doi: 10.1016/0032-5910(93)80041-8. [DOI] [Google Scholar]
- 15.The British Pharmacopoeia. London, UK: Her Majesty's Stationary Office: 1980.
- 16.United States Pharmacopoeial Convention.United States Pharmacopoeia. Rockville, MD: US Pharmacopoeia; 1995.
- 17.Miyamoto Y, Ogawa S, Miyajima M, Sato H, Takayama K, Nagai T. An evaluation of process variables in wet granulation. Drug Dev Ind Pharm. 1995;21:2213–2225. doi: 10.3109/03639049509065902. [DOI] [Google Scholar]
- 18.Pawar AP. Studies on spherical crystallization of various pharmaceuticals. Pune, India: Bharati Vidyapeeth, University of Pune; 1999. [Google Scholar]
- 19.Pawar PH, Pawar AP, Mahadik KR, Paradkar AR. Evaluation of tabletting properties of agglomerates obtained by spherical crystallization of trimethoprim. Indian J Pharm Sci. 1998;60:24–28. [Google Scholar]
- 20.Heckel RW. Density-pressure relationships in powder compaction. Trans Metall Soc AIME. 1961;221:671–675. [Google Scholar]
- 21.Heckel RW. An analysis of powder compaction phenomena. Trans Metall Soc AIME. 1961;221:1001–1008. [Google Scholar]
- 22.Rubinstein MH, Musikabhumma P. A universal friability test for tablet granules. Pharm Acta Helv. 1978;53:125–129. [PubMed] [Google Scholar]
- 23.Wells JI. Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances. New York, NY: Wiley; 1998. pp. 1–47. [Google Scholar]
- 24.Shah YI, Paradkar AR, Dhayagude MG. Introduction to Biostatistics and Computer Science. 1st ed. Pune, India: Nirali Prakashan; 2007. [Google Scholar]
- 25.Kawashima Y, Handa T, Hirofumi T, Okumura M. Effects of polyethylene glycol on size of agglomerated crystals of phenytoin prepared by the spherical crystallization technique. Chem Pharm Bull (Tokyo) 1986;34:3403–3407. doi: 10.1248/cpb.34.3403. [DOI] [PubMed] [Google Scholar]
- 26.Kawashima Y, Handa T, Tekeuchi H, Okumara M, Katou H, Nagata O. Crystal modification of phenytoin with polyethylene glycol for improving mechanical strength, dissolution rate and bioavailability by spherical crystallization technique. Chem Pharm Bull (Tokyo) 1986;34:3376–3383. doi: 10.1248/cpb.34.3376. [DOI] [PubMed] [Google Scholar]
- 27.Lalla JK, Bhat SU. A look at process costing and cost effectiveness of a pharmaceutical formulation. Indian Drugs. 1995;32:551–560. [Google Scholar]
- 28.Sanghavi NM, Sivanand R, Kotwaney HN. Dissolution pattern of miniscular sulfisoxazole. Ind J Pharm Sci. 1979;41:116–117. [Google Scholar]
- 29.Alsaidan SM, Abdulhakeem AA, Eshra AG. Improved dissolution rate of indomethacin by adsorbents. Drug Dev, Ind Pharm. 1998;24:389–394. doi: 10.3109/03639049809085635. [DOI] [PubMed] [Google Scholar]